Ginkgo Bioworks Holdings (DNA) Shares Outstanding (2019 - 2026)

Ginkgo Bioworks Holdings (DNA) has 8 years of Shares Outstanding data on file, last reported at $65.1 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 19.08% year-over-year to $65.1 million; the trailing twelve-month figure through Mar 2026 stood at $65.1 million (up 19.08% YoY), and the FY2025 full-year result was $61.7 million, up 13.45% from the prior year.
• Shares Outstanding for Q1 2026 stood at $65.1 million, up from $61.7 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $1.9 billion in Q1 2023 and bottomed at $47.3 million in Q4 2022.
• The 5-year median for Shares Outstanding is $54.7 million (2025), against an average of $443.5 million.
• The widest annual swing landed in 2022, when Shares Outstanding gained 26.45%; it then plunged 97.37% in 2024.
• A 5-year view of Shares Outstanding shows it stood at $47.3 million in 2022, then gained by 5.78% to $50.0 million in 2023, then increased by 8.66% to $54.4 million in 2024, then rose by 13.45% to $61.7 million in 2025, then rose by 5.6% to $65.1 million in 2026.
• The last three Shares Outstanding figures came in at $65.1 million (Q1 2026), $61.7 million (Q4 2025), and $60.3 million (Q3 2025), per Business Quant data.

Peer Comparison